CN102680442B - A method for label-free fluorescent detection of trypsin - Google Patents
A method for label-free fluorescent detection of trypsin Download PDFInfo
- Publication number
- CN102680442B CN102680442B CN201210116073.8A CN201210116073A CN102680442B CN 102680442 B CN102680442 B CN 102680442B CN 201210116073 A CN201210116073 A CN 201210116073A CN 102680442 B CN102680442 B CN 102680442B
- Authority
- CN
- China
- Prior art keywords
- solution
- trypsin
- concentration
- detection
- fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域 technical field
本发明一种无标记荧光检测胰蛋白酶的方法,属于材料、生物、和分析化学交叉学科的技术领域,具体涉及到一种基于超分子组装体在酶催化水解作用下解组装来实现胰蛋白酶检测的方法的技术方案。 The invention discloses a method for detecting trypsin with unlabeled fluorescence, which belongs to the technical field of interdisciplinary materials, biology, and analytical chemistry, and specifically relates to a method for realizing trypsin detection based on supramolecular assembly disassembly under enzyme-catalyzed hydrolysis The technical solution of the method.
背景技术 Background technique
胰蛋白酶是蛋白质分解中最重要的消化酶之一,胰蛋白酶原的分泌、活化、抑制以及循环的不平衡会导致急性或慢性的胰腺疾病,严重的例如胰腺癌。胰腺癌是恶性度最高、预后最差的一种肿瘤,患者的5年生存率一般不到5%,大约每年有35000例胰腺癌是由于丝氨酸蛋白酶尤其是胰蛋白酶的不平衡引起的。此外胰蛋白酶不仅起消化酶的作用,而且还能限制分解糜蛋白酶原、羧肽酶原、磷脂酶原等其它酶的前体,起活化作用。 Trypsin is one of the most important digestive enzymes in protein decomposition. The secretion, activation, inhibition and circulation imbalance of trypsinogen can lead to acute or chronic pancreatic diseases, such as pancreatic cancer. Pancreatic cancer is the most malignant tumor with the worst prognosis. The 5-year survival rate of patients is generally less than 5%. About 35,000 cases of pancreatic cancer are caused by the imbalance of serine proteases, especially trypsin, every year. In addition, trypsin not only acts as a digestive enzyme, but also restricts the decomposition of precursors of other enzymes such as chymotrypsinogen, carboxypeptidase, and phospholipase, and activates them.
目前发展起来的测定胰蛋白酶的方法主要有紫外分光光度法、比色法、荧光法、免疫法、放射性元素标记法、质谱法(MS)、液相色谱法(HPLC)、电泳法等。紫外法和比色法操作简单,但灵敏度低,重现性差。免疫法灵敏度高,如专利201020245770.x所述,但由于单克隆抗体的使用使得成本也高,且需要一定的操作技术。放射性元素标记法需要对底物进行标记,制备复杂并且有一定的安全性问题等等。质谱仪器昂贵,对样品的纯度要求高,色谱以及电泳法需要比较复杂的操作和较长的检测时间。 Currently developed methods for the determination of trypsin mainly include UV spectrophotometry, colorimetry, fluorescence, immunoassay, radioactive element labeling, mass spectrometry (MS), liquid chromatography (HPLC), electrophoresis, etc. Ultraviolet and colorimetric methods are simple to operate, but have low sensitivity and poor reproducibility. Immunization method has high sensitivity, as described in patent 201020245770.x, but the cost is high due to the use of monoclonal antibodies, and certain operating techniques are required. The radioactive element labeling method needs to label the substrate, which is complicated to prepare and has certain safety problems and so on. Mass spectrometry instruments are expensive and require high purity of samples, while chromatography and electrophoresis require relatively complicated operations and long detection times.
相比这些方法,荧光法操作简便、灵敏度高、可实现实时监测,具有临床应用的潜在可能。但一般的荧光法需要荧光标记底物,制备复杂且提高了成本,使其应用受到限制,近年来无标记的方法受到关注。目前报道的无标记荧光检测的方法主要是应用水溶性荧光共轭聚合物以及新型的聚集诱导发光分子,这些分子的合成与分离仍然比较复杂。因而建立试剂易得,制备简单的荧光检测方法具有重要的意义。通过检索,未见无标记荧光检测胰蛋白酶的方法。 Compared with these methods, the fluorescence method is easy to operate, has high sensitivity, can realize real-time monitoring, and has the potential of clinical application. However, the general fluorescence method requires a fluorescently labeled substrate, which is complicated to prepare and increases the cost, which limits its application. In recent years, label-free methods have attracted attention. The currently reported methods for label-free fluorescence detection mainly use water-soluble fluorescent conjugated polymers and new aggregation-induced luminescent molecules. The synthesis and separation of these molecules are still relatively complicated. Therefore, it is of great significance to establish a reagent that is easy to obtain and to prepare a simple fluorescence detection method. Through searching, there is no method for label-free fluorescent detection of trypsin.
发明内容 Contents of the invention
本发明一种无标记荧光检测胰蛋白酶的方法的目的是克服现有技术的不足,提供一种操作简单、快速、灵敏、无须有机合成的无标记荧光检测胰蛋白酶方法。 The purpose of the method for detecting trypsin with unlabeled fluorescence is to overcome the deficiencies of the prior art and provide a method for detecting trypsin with unlabeled fluorescence that is simple, fast, sensitive and does not require organic synthesis.
本发明一种无标记荧光检测胰蛋白酶的方法,其特征在于是一种基于超分子组装体在酶催化水解作用下解组装来实现胰蛋白酶检测的方法,其具体步骤为: A method for detecting trypsin with unlabeled fluorescence of the present invention is characterized in that it is a method for realizing trypsin detection based on supramolecular assembly disassembly under enzyme-catalyzed hydrolysis, and its specific steps are:
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
以疏水染料为荧光探针,将疏水染料溶解到市售光谱纯丙酮、氯仿或甲醇的有机溶剂中,配制浓度为 10-3 ~ 10-6mol L-1荧光探针的有机溶液; Use hydrophobic dyes as fluorescent probes, dissolve the hydrophobic dyes in organic solvents such as commercially available spectrum pure acetone, chloroform or methanol, and prepare an organic solution with a concentration of 10 -3 ~ 10 -6 mol L -1 fluorescent probes;
Ⅱ 测定表面活性剂的临界胶束浓度CMC: Ⅱ Determination of critical micelle concentration CMC of surfactant:
将表面活性剂溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,配制浓度范围为1mol L-1~10-7mol L-1的梯度溶液,用微量进样器移取步骤Ⅰ配制的荧光探针有机溶液,加入到梯度溶液中,使梯度溶液中探针的终浓度为10-8 ~10-6 mol L-1,以40~100kHz敞口超声波处理10~60分钟,静置0.5~12小时后进行荧光光谱检测,测定表面活性剂的临界胶束浓度CMC; Dissolve the surfactant in a phosphate buffer solution with a concentration of 10 mM and pH 8.0 to prepare a gradient solution with a concentration ranging from 1 mol L -1 to 10 -7 mol L -1 , and use a micro-injector to pipette step Ⅰ to prepare The organic solution of the fluorescent probe was added to the gradient solution, so that the final concentration of the probe in the gradient solution was 10 -8 ~10 -6 mol L -1 , treated with 40 ~ 100kHz exposure ultrasonic wave for 10 ~ 60 minutes, and let it stand After 0.5 to 12 hours, perform fluorescence spectrum detection to measure the critical micelle concentration CMC of the surfactant;
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
根据步骤Ⅱ得到的表面活性剂的临界胶束浓度CMC,确定表面活性剂浓度为0.1~1.6CMC,将带相反电荷的聚电解质溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中制成聚电解质溶液;按照聚电解质与表面活性剂电荷比为1:1,在表面活性剂的溶液中加入等体积的聚电解质溶液,表面活性剂与带相反电荷的聚电解质通过疏水与静电作用形成超分子组装体,混合均匀,静置10~15分钟,得到超分子组装体溶液,该超分子组装体溶液的重量百分浓度为0.01~0.2%; According to the critical micelle concentration CMC of the surfactant obtained in step Ⅱ, the concentration of the surfactant is determined to be 0.1~1.6 CMC, and the oppositely charged polyelectrolyte is dissolved in a phosphate buffer solution with a concentration of 10 mM and a pH of 8.0. Polyelectrolyte solution: According to the charge ratio of polyelectrolyte and surfactant being 1:1, add an equal volume of polyelectrolyte solution to the surfactant solution, and the surfactant and the oppositely charged polyelectrolyte form a superhydrophobic and electrostatic interaction. The molecular assembly is uniformly mixed, and left to stand for 10 to 15 minutes to obtain a supramolecular assembly solution, and the weight percent concentration of the supramolecular assembly solution is 0.01 to 0.2%;
Ⅳ 配制检测液: Ⅳ Preparation of test solution:
再次用微量进样器移取步骤Ⅰ配制的荧光探针有机溶液,分别加入到Ⅲ所得到的超分子组装体溶液中,使该超分子组装体溶液中探针的终浓度为10-8~10-6mol L-1,以40~100kHz敞口超声波处理10~60分钟,静置0.5~12小时后得到检测液; Pipette the fluorescent probe organic solution prepared in step I again with a microsampler, and add them to the supramolecular assembly solution obtained in III, so that the final concentration of the probe in the supramolecular assembly solution is 10 -8 ~ 10 -6 mol L -1 , treated with 40-100kHz exposure ultrasonic treatment for 10-60 minutes, and obtained the test solution after standing for 0.5-12 hours;
Ⅴ 测定催化水解时间: Ⅴ Determination of catalytic hydrolysis time:
步骤Ⅳ得到的检测液在35~37℃下培养10~15分钟,将胰蛋白酶溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,在检测液中分别加入相同体积的胰蛋白酶缓冲溶液,以只加入缓冲溶液作为空白对照,胰蛋白酶终浓度范围为0.01~100 μg mL-1,在35~37℃下进行荧光光谱跟踪检测,以荧光发射峰强度下降的比率对时间作图,得到不同浓度胰蛋白酶催化水解条件下荧光发射峰强度线性下降的时间范围; Incubate the test solution obtained in step IV for 10-15 minutes at 35-37°C, dissolve trypsin in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and add the same volume of trypsin buffer solution to the test solution , using only buffer solution as a blank control, the final concentration of trypsin ranges from 0.01 to 100 μg mL -1 , and the fluorescence spectrum tracking detection is carried out at 35 to 37°C, and the ratio of the decrease in fluorescence emission peak intensity is plotted against time, and The time range for the linear decrease of fluorescence emission peak intensity under different concentrations of trypsin-catalyzed hydrolysis conditions;
Ⅵ 测定胰蛋白酶活性: Ⅵ Determination of trypsin activity:
根据步骤Ⅴ得到的时间范围,取各浓度条件下共同线性时间范围的最大值,以荧光发射峰强度下降的比率对加入胰蛋白酶浓度作图,得到检测标准曲线。 According to the time range obtained in step V, the maximum value of the common linear time range under each concentration condition was taken, and the ratio of the decrease in fluorescence emission peak intensity was plotted against the concentration of trypsin added to obtain a detection standard curve.
上述一种无标记荧光检测胰蛋白酶的方法,其特征在于所述的疏水染料为市售纯度高于98%的芘、尼罗红、香豆素481、苏丹红或氟硼荧染料BODIPY,氟硼荧染料BODIPY是指BODIPY FL、BODIPY R6G、BODIPY TMR、BODIPY 581/591、BODIPY TR或BODIPY 630/650。 The above-mentioned method for label-free fluorescent detection of trypsin is characterized in that the hydrophobic dye is commercially available pyrene, Nile red, coumarin 481, Sudan red or fluoroboron dye BODIPY with a purity higher than 98%. BODIPY refers to BODIPY FL, BODIPY R6G, BODIPY TMR, BODIPY 581/591, BODIPY TR or BODIPY 630/650.
上述一种无标记荧光检测胰蛋白酶的方法,其特征在于所述的表面活性剂为带负电荷的烷基硫酸盐或烷基磺酸盐,烷基硫酸盐为市售分析纯十二烷基硫酸钠、十四烷基硫酸钠或十六烷基硫酸钠;烷基磺酸盐为市售分析纯十二烷基磺酸钠、十四烷基磺酸钠或十六烷基磺酸钠。 The above-mentioned method for label-free fluorescent detection of trypsin is characterized in that the surfactant is a negatively charged alkyl sulfate or alkyl sulfonate, and the alkyl sulfate is commercially available analytically pure dodecyl Sodium sulfate, sodium tetradecyl sulfate, or sodium cetyl sulfate; alkylsulfonates are commercial analytical grade sodium dodecyl sulfate, sodium tetradecyl sulfate, or sodium cetyl sulfate .
上述一种无标记荧光检测胰蛋白酶的方法,其特征在于所述的聚电解质是可以被胰蛋白酶催化水解的多肽,多肽为市售纯度高于99%的,长度为10~16的带正电荷的精氨酸序列Arg 10 ~ Arg 16 。 The above method for label-free fluorescent detection of trypsin is characterized in that the polyelectrolyte is a polypeptide that can be catalyzed and hydrolyzed by trypsin, and the polypeptide is commercially available with a purity higher than 99% and a length of 10-16 positively charged Arginine sequence Arg 10 ~ Arg 16 .
本发明一种无标记荧光检测胰蛋白酶活性的方法与现技术相比具有的有益效果: Compared with the prior art, a method for label-free fluorescent detection of trypsin activity of the present invention has beneficial effects:
1)通过超分子组装体解组装的方式进行检测,不需要复杂的有机合成和固定过程,制备简单、成本低、无污染; 1) Detection is carried out through the disassembly of supramolecular assemblies, which does not require complex organic synthesis and immobilization processes, and is simple to prepare, low in cost, and pollution-free;
2)在超分子组装体内部包埋荧光染料,通过荧光方法进行检测,灵敏度高,检测时间短,容易实现实时检测。 2) Fluorescent dyes are embedded in the supramolecular assembly, and detected by fluorescence method, which has high sensitivity, short detection time, and easy real-time detection.
附图说明 Description of drawings
图1是表面活性剂十二烷基硫酸钠(SDS)的临界胶束浓度测定曲线; Fig. 1 is the critical micelle concentration determination curve of surfactant sodium dodecyl sulfate (SDS);
图2是表面活性剂十二烷基硫酸钠(SDS)分别与不同长度的多肽(Arg 10 与Arg 6 )组装行为的差异。 Figure 2 shows the differences in the assembly behaviors of surfactant sodium dodecyl sulfate (SDS) and polypeptides of different lengths (Arg 10 and Arg 6 ).
具体实施方式 Detailed ways
以疏水染料作为荧光探针,首先测定了表面活性剂的临界胶束浓度,然后在表面活性剂临界胶束浓度以下,表面活性剂与带相反电荷的聚电解质通过疏水与静电作用形成超分子组装体,疏水染料包埋于组装体内腔,最后加入对聚电解质有水解作用的酶,将高分子量的聚电解质催化水解为低分子量的聚电解质,诱导组装体解组装,使组装体内腔包埋的荧光探针释放,通过荧光强度的降低来实现酶活性的检测。下面的实施方式是对本发明的进一步说明,而不是限制本发明的范围。 Using a hydrophobic dye as a fluorescent probe, the critical micelle concentration of the surfactant was firstly determined, and then below the critical micelle concentration of the surfactant, the surfactant and the oppositely charged polyelectrolyte formed a supramolecular assembly through hydrophobic and electrostatic interactions The hydrophobic dye is embedded in the lumen of the assembly, and finally an enzyme that hydrolyzes the polyelectrolyte is added to catalyze the hydrolysis of the high-molecular-weight polyelectrolyte into a low-molecular-weight polyelectrolyte, which induces the disassembly of the assembly and makes the assembly lumen-embedded The fluorescent probe is released, and the detection of enzyme activity is realized through the reduction of fluorescence intensity. The following embodiments are further descriptions of the present invention, rather than limiting the scope of the present invention.
实施方式1: Implementation mode 1:
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
以芘为荧光探针,将芘溶解到丙酮中,在10 mL容量瓶中配制浓度为10-2 mol L-1芘的丙酮溶液,进一步用丙酮稀释到10-5 mol L-1; Using pyrene as a fluorescent probe, dissolve pyrene in acetone, prepare an acetone solution with a concentration of 10 -2 mol L -1 pyrene in a 10 mL volumetric flask, and further dilute to 10 -5 mol L -1 with acetone;
Ⅱ 测定表面活性剂的临界胶束浓度CMC: Ⅱ Determination of critical micelle concentration CMC of surfactant:
将十二烷基硫酸钠SDS溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,在10 mL容量瓶中配制10-2 mol L-1的溶液,进一步用缓冲液做倍比稀释,得到浓度范围为1mol L-1~10-7mol L-1的梯度溶液; Sodium dodecyl sulfate SDS was dissolved in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and a solution of 10 -2 mol L -1 was prepared in a 10 mL volumetric flask, and further diluted with buffer solution, Obtain a gradient solution with a concentration range of 1mol L -1 ~10 -7 mol L -1 ;
用微量进样器移取步骤Ⅰ配制得到的荧光探针的有机溶液,分别加入到配制的梯度溶液中,使梯度溶液中荧光探针的终浓度为5×10-7mol L-1。以100kHz敞口超声波处理10 分钟,静置0.5小时后检测荧光激发光谱。 Use a microsampler to pipette the organic solution of the fluorescent probe prepared in step I, and add it to the prepared gradient solution, so that the final concentration of the fluorescent probe in the gradient solution is 5×10 -7 mol L -1 . Ultrasonic treatment was performed at 100 kHz for 10 minutes, and the fluorescence excitation spectrum was detected after standing for 0.5 hour.
以荧光激发光谱I 338 /I 333 的比值对表面活性剂浓度的对数值作图,拟合得到s型曲线,曲线的第一个突变点对应浓度即为表面活性剂的临界胶束浓度。荧光光谱测定得到表面活性剂的临界胶束浓度。 The ratio of the fluorescence excitation spectrum I 338 /I 333 was plotted against the logarithmic value of the surfactant concentration, and an s-shaped curve was obtained by fitting. The concentration corresponding to the first abrupt point of the curve was the critical micelle concentration of the surfactant. The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
确定表面活性剂浓度为0.6 CMC,将Arg10溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,按照聚电解质与表面活性剂电荷比为1:1加入等体积的Arg10的缓冲溶液,表面活性剂与带相反电荷的聚电解质通过疏水与静电作用构建超分子组装体,混合均匀,静置10分钟,得到组装体溶液,组装体溶液的重量百分浓度为0.075%; Determine the surfactant concentration as 0.6 CMC, dissolve Arg 10 in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and add an equal volume of Arg 10 buffer solution according to the charge ratio of polyelectrolyte to surfactant at 1:1 , the surfactant and the oppositely charged polyelectrolyte construct a supramolecular assembly through hydrophobic and electrostatic interactions, mix evenly, and let stand for 10 minutes to obtain an assembly solution, the weight percent concentration of which is 0.075%;
Ⅳ 配制检测液: Ⅳ Preparation of test solution:
再次用微量进样器移取步骤Ⅰ配制的荧光探针有机溶液,分别加入到Ⅲ所得到的组装体溶液中,使组装体溶液中荧光探针的终浓度为5×10-7mol L-1,以100kHz敞口超声波处理10分钟,静置0.5小时后得到检测液; Pipette the fluorescent probe organic solution prepared in step I again with a microsampler, and add them to the assembly solution obtained in III, so that the final concentration of the fluorescent probe in the assembly solution is 5×10 -7 mol L - 1. Ultrasonic treatment at 100kHz for 10 minutes, and after standing for 0.5 hours, the test solution was obtained;
Ⅴ 测定催化水解时间: Ⅴ Determination of catalytic hydrolysis time:
步骤Ⅳ得到的检测液中在35℃下培养10分钟,将胰蛋白酶溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,在检测液中分别加入相同体积不同浓度的胰蛋白酶,以加入缓冲溶液作为空白对照,浓度范围从0.01到 100μg mL-1,在35℃下进行荧光光谱跟踪检测,以荧光发射峰强度下降的比率对时间作图,得到不同浓度胰蛋白酶催化水解条件下荧光发射峰强度线性下降的时间范围; Incubate the test solution obtained in step IV at 35°C for 10 minutes, dissolve trypsin in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and add the same volume of trypsin with different concentrations to the test solution to add The buffer solution was used as a blank control, the concentration ranged from 0.01 to 100 μg mL -1 , and the fluorescence spectrum tracking detection was carried out at 35°C. The ratio of the decrease of the fluorescence emission peak intensity was plotted against the time, and the fluorescence emission under different concentrations of trypsin catalyzed hydrolysis conditions was obtained. The time range in which the peak intensity decreases linearly;
Ⅵ 测定胰蛋白酶活性: Ⅵ Determination of trypsin activity:
根据步骤Ⅴ得到的时间范围,取各浓度条件下共同线性时间范围的最大值,以荧光发射峰强度下降的比率对加入胰蛋白酶浓度作图,得到检测标准曲线。 According to the time range obtained in step V, the maximum value of the common linear time range under each concentration condition was taken, and the ratio of the decrease in fluorescence emission peak intensity was plotted against the concentration of trypsin added to obtain a detection standard curve.
荧光强度下降的比率为 (I-I0)/I0 ×100 %,I0代表只加缓冲溶液的空白对照荧光发射峰处荧光强度,I 代表加入不同浓度胰蛋白酶后发射峰处荧光强度。 The ratio of fluorescence intensity decrease is (II 0 )/I 0 ×100 %, I 0 represents the fluorescence intensity at the fluorescence emission peak of the blank control with only buffer solution added, and I represents the fluorescence intensity at the emission peak after adding different concentrations of trypsin.
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验:在相同测试条件下,在组装体溶液中分别加入相同浓度的碱性磷酸酶、溶菌酶、葡萄糖氧化酶、胰蛋白酶,37℃下培养半小时后进行荧光光谱检测。 Specificity experiment: under the same test conditions, the same concentrations of alkaline phosphatase, lysozyme, glucose oxidase, and trypsin were added to the assembly solution, and the fluorescence spectrum was detected after incubation at 37°C for half an hour.
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式2 Embodiment 2
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
以尼罗红为荧光探针,将尼罗红溶解到甲醇中,在10 mL容量瓶中配制浓度为10-1 mol L-1尼罗红的甲醇溶液,进一步用甲醇稀释到10-3 mol L-1; Using Nile Red as a fluorescent probe, dissolve Nile Red in methanol, prepare a methanol solution with a concentration of 10 -1 mol L -1 Nile Red in a 10 mL volumetric flask, and further dilute to 10 -3 mol with methanol L -1 ;
Ⅱ 测定表面活性剂的临界胶束浓度CMC: Ⅱ Determination of critical micelle concentration CMC of surfactant:
将十四烷基硫酸钠溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,在10 mL容量瓶中配制10-2 mol L-1的溶液,进一步用缓冲液做倍比稀释,得到浓度范围为1mol L-1 ~10-7mol L-1的梯度溶液; Sodium tetradecyl sulfate was dissolved in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and a solution of 10 -2 mol L -1 was prepared in a 10 mL volumetric flask, and further diluted with buffer solution to obtain Gradient solution with a concentration range of 1mol L -1 ~10 -7 mol L -1 ;
用微量进样器移取步骤Ⅰ配制得到的荧光探针的有机溶液,分别加入到配制的梯度溶液中,使梯度溶液中荧光探针的终浓度为10-6 mol L-1。以70 kHz敞口超声波处理30分钟,静置1小时后检测荧光激发光谱。 Use a microsampler to pipette the organic solution of the fluorescent probe prepared in step I, and add it to the prepared gradient solution, so that the final concentration of the fluorescent probe in the gradient solution is 10 -6 mol L -1 . Ultrasonic treatment was performed at 70 kHz for 30 minutes, and the fluorescence excitation spectrum was detected after standing for 1 hour.
以荧光发射光谱发射峰强度对表面活性剂浓度对数值作图,拟合得到s型曲线,曲线的第一个突变点对应浓度即为表面活性剂的临界胶束浓度。荧光光谱测定得到表面活性剂的临界胶束浓度。 The emission peak intensity of the fluorescence emission spectrum is plotted against the logarithmic value of the surfactant concentration, and an s-shaped curve is obtained by fitting, and the concentration corresponding to the first mutation point of the curve is the critical micelle concentration of the surfactant. The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
固定表面活性剂浓度为0.1CMC,将Arg16溶解于浓度为10 mM,pH8.0的磷酸盐缓冲溶液中,按照聚电解质与表面活性剂电荷比为1:1加入等体积的Arg16的缓冲溶液,表面活性剂与带相反电荷的聚电解质通过疏水与静电作用构建超分子组装体,混合均匀,静置15分钟,得到组装体溶液,组装体溶液的重量百分浓度为0.01%; Fix the surfactant concentration at 0.1CMC, dissolve Arg 16 in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and add an equal volume of Arg 16 buffer according to the charge ratio of polyelectrolyte to surfactant at 1:1. The solution, the surfactant and the oppositely charged polyelectrolyte construct a supramolecular assembly through hydrophobic and electrostatic interactions, mix evenly, and let stand for 15 minutes to obtain an assembly solution, and the weight percent concentration of the assembly solution is 0.01%;
Ⅳ 配制检测液: Ⅳ Preparation of test solution:
再次用微量进样器移取步骤Ⅰ配制的荧光探针有机溶液,分别加入到Ⅲ所得到的组装体溶液中,使组装体溶液中探针的终浓度为10-6 mol L-1,以70kHz敞口超声波处理30分钟,静置1小时后得到检测液; Pipette the fluorescent probe organic solution prepared in step I again with a microsampler, and add them to the assembly solution obtained in III respectively, so that the final concentration of the probe in the assembly solution is 10 -6 mol L -1 . 70kHz exposed ultrasonic treatment for 30 minutes, and after standing for 1 hour, the test solution was obtained;
Ⅴ 测定催化水解时间: Ⅴ Determination of catalytic hydrolysis time:
步骤Ⅳ得到的检测液中在37℃下培养15分钟,将胰蛋白酶溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,在检测液中分别加入相同体积不同浓度的胰蛋白酶,以加入缓冲溶液作为空白对照,浓度范围从0.01到 100μg mL-1,在37℃下进行荧光光谱跟踪检测,以荧光发射峰强度下降的比率对时间作图,得到不同浓度胰蛋白酶催化水解条件下荧光发射峰强度线性下降的时间范围; Incubate the test solution obtained in step IV at 37°C for 15 minutes, dissolve trypsin in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and add the same volume of trypsin with different concentrations to the test solution to add The buffer solution was used as a blank control, the concentration ranged from 0.01 to 100 μg mL -1 , and the fluorescence spectrum tracking was carried out at 37°C. The ratio of the decrease of the fluorescence emission peak intensity was plotted against the time, and the fluorescence emission under different concentrations of trypsin catalyzed hydrolysis conditions was obtained. The time range in which the peak intensity decreases linearly;
Ⅵ 测定胰蛋白酶活性: Ⅵ Determination of trypsin activity:
根据步骤Ⅴ得到的时间范围,取各浓度条件下共同线性时间范围的最大值,以荧光发射峰强度下降的比率对加入胰蛋白酶浓度作图,得到检测标准曲线。 According to the time range obtained in step V, the maximum value of the common linear time range under each concentration condition was taken, and the ratio of the decrease in fluorescence emission peak intensity was plotted against the concentration of trypsin added to obtain a detection standard curve.
荧光强度下降的比率为 (I-I0)/I0 ×100 %,I0代表只加缓冲溶液的空白对照荧光发射峰处荧光强度,I 代表加入不同浓度胰蛋白酶后发射峰处荧光强度。 The ratio of fluorescence intensity decrease is (II 0 )/I 0 ×100 %, I 0 represents the fluorescence intensity at the fluorescence emission peak of the blank control with only buffer solution added, and I represents the fluorescence intensity at the emission peak after adding different concentrations of trypsin.
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验:在相同测试条件下,在组装体溶液中分别加入相同浓度的碱性磷酸酶、溶菌酶、葡萄糖氧化酶、胰蛋白酶,37℃下培养半小时后进行荧光光谱检测。 Specificity experiment: under the same test conditions, the same concentrations of alkaline phosphatase, lysozyme, glucose oxidase, and trypsin were added to the assembly solution, and the fluorescence spectrum was detected after incubation at 37°C for half an hour.
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式3 Embodiment 3
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
以苏丹红为荧光探针,将苏丹红溶解到氯仿中,在10 mL容量瓶中配制浓度为10-1mol L-1苏丹红的氯仿溶液,进一步用氯仿稀释到10-3 mol L-1; Using Sudan Red as a fluorescent probe, dissolve Sudan Red in chloroform, prepare a Sudan Red chloroform solution with a concentration of 10 -1 mol L -1 in a 10 mL volumetric flask, and further dilute to 10 -3 mol L -1 with chloroform ;
Ⅱ 测定表面活性剂的临界胶束浓度CMC: Ⅱ Determination of critical micelle concentration CMC of surfactant:
将十六烷基硫酸钠溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,在10 mL容量瓶中配制10-2 mol L-1的溶液,进一步用缓冲液做倍比稀释,得到浓度范围为1mol L-1 ~10-7mol L-1的梯度溶液; Sodium cetyl sulfate was dissolved in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and a solution of 10 -2 mol L -1 was prepared in a 10 mL volumetric flask, and further diluted with buffer solution to obtain Gradient solution with a concentration range of 1mol L -1 ~10 -7 mol L -1 ;
用微量进样器移取步骤Ⅰ配制得到的荧光探针的有机溶液,分别加入到配制的梯度溶液中,使梯度溶液中荧光探针的终浓度为10-6 mol L-1。以40 kHz敞口超声波处理60分钟,静置12小时后检测荧光激发光谱。 Use a microsampler to pipette the organic solution of the fluorescent probe prepared in step I, and add it to the prepared gradient solution, so that the final concentration of the fluorescent probe in the gradient solution is 10 -6 mol L -1 . Ultrasonic treatment was performed at 40 kHz for 60 minutes, and the fluorescence excitation spectrum was detected after standing for 12 hours.
以荧光发射光谱发射峰强度对表面活性剂浓度对数值作图,拟合得到s型曲线,曲线的第一个突变点对应浓度即为表面活性剂的临界胶束浓度。荧光光谱测定得到表面活性剂的临界胶束浓度。 The emission peak intensity of the fluorescence emission spectrum is plotted against the logarithmic value of the surfactant concentration, and an s-shaped curve is obtained by fitting, and the concentration corresponding to the first mutation point of the curve is the critical micelle concentration of the surfactant. The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
固定表面活性剂浓度为0.8 CMC,将Arg12溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,按照聚电解质与表面活性剂电荷比为1:1加入等体积的Arg16的缓冲溶液,表面活性剂与带相反电荷的聚电解质通过疏水与静电作用构建超分子组装体,混合均匀,静置10分钟,得到组装体溶液,组装体溶液的重量百分浓度为0.12%; Fix the surfactant concentration at 0.8 CMC, dissolve Arg 12 in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and add an equal volume of Arg 16 buffer solution according to the charge ratio of polyelectrolyte to surfactant at 1:1 , the surfactant and the oppositely charged polyelectrolyte construct a supramolecular assembly through hydrophobic and electrostatic interactions, mix evenly, and let stand for 10 minutes to obtain an assembly solution, the weight percent concentration of which is 0.12%;
Ⅳ 配制检测液: Ⅳ Preparation of test solution:
再次用微量进样器移取步骤Ⅰ配制的荧光探针有机溶液,分别加入到Ⅲ所得到的混合溶液中,使混合溶液中探针的终浓度为10-6 mol L-1,以40kHz敞口超声波处理60分钟,静置12小时后得到检测液; Pipette the fluorescent probe organic solution prepared in step I again with a micro-sampler, and add them to the mixed solution obtained in III, so that the final concentration of the probe in the mixed solution is 10 -6 mol L -1 . Ultrasonic treatment was performed for 60 minutes, and the test solution was obtained after standing for 12 hours;
Ⅴ 测定催化水解时间: Ⅴ Determination of catalytic hydrolysis time:
步骤Ⅳ得到的检测液中在37℃下培养10分钟,将胰蛋白酶溶解于浓度为10 mM,pH 8.0的磷酸盐缓冲溶液中,在检测液中分别加入相同体积不同浓度的胰蛋白酶,以加入缓冲溶液作为空白对照,浓度范围从0.01到 100μg mL-1,在37℃下进行荧光光谱跟踪检测,以荧光发射峰强度下降的比率对时间作图,得到不同浓度胰蛋白酶催化水解条件下荧光发射峰强度线性下降的时间范围; Incubate the test solution obtained in step IV at 37°C for 10 minutes, dissolve trypsin in a phosphate buffer solution with a concentration of 10 mM and pH 8.0, and add the same volume of trypsin with different concentrations to the test solution to add The buffer solution was used as a blank control, the concentration ranged from 0.01 to 100 μg mL -1 , and the fluorescence spectrum tracking was carried out at 37°C. The ratio of the decrease of the fluorescence emission peak intensity was plotted against the time, and the fluorescence emission under different concentrations of trypsin catalyzed hydrolysis conditions was obtained. The time range in which the peak intensity decreases linearly;
Ⅵ 测定胰蛋白酶活性: Ⅵ Determination of trypsin activity:
根据步骤Ⅴ得到的时间范围,取各浓度条件下共同线性时间范围的最大值,以荧光发射峰强度下降的比率对加入胰蛋白酶浓度作图,得到检测标准曲线。 According to the time range obtained in step V, the maximum value of the common linear time range under each concentration condition was taken, and the ratio of the decrease in fluorescence emission peak intensity was plotted against the concentration of trypsin added to obtain a detection standard curve.
荧光强度下降的比率为 (I-I0)/I0 ×100 %,I0代表只加缓冲溶液的空白对照荧光发射峰处荧光强度,I 代表加入不同浓度胰蛋白酶后发射峰处荧光强度。荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The ratio of fluorescence intensity decrease is (II 0 )/I 0 ×100 %, I 0 represents the fluorescence intensity at the fluorescence emission peak of the blank control with only buffer solution added, and I represents the fluorescence intensity at the emission peak after adding different concentrations of trypsin. The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验:在相同测试条件下,在组装体溶液中分别加入相同浓度的碱性磷酸酶、溶菌酶、葡萄糖氧化酶、胰蛋白酶,37℃下培养半小时后进行荧光光谱检测。 Specificity experiment: under the same test conditions, the same concentrations of alkaline phosphatase, lysozyme, glucose oxidase, and trypsin were added to the assembly solution, and the fluorescence spectrum was detected after incubation at 37°C for half an hour.
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式4 Embodiment 4
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
除所用荧光探针为香豆素481,其他同实施方式2; Except that the fluorescent probe used is Coumarin 481, the others are the same as Embodiment 2;
Ⅱ 测定表面活性剂的临界胶束浓度CMC: Ⅱ Determination of critical micelle concentration CMC of surfactant:
除所用表面活性剂为十二烷基磺酸钠,其他同实施方式2; Except that surfactant used is sodium dodecylsulfonate, other is with embodiment 2;
荧光光谱测定得到表面活性剂的临界胶束浓度。 The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
除表面活性剂浓度为1.6CMC,所用聚电解质为Arg 14 ,组装体溶液的重量百分浓度为2%,其他同实施方式1;
Except that the surfactant concentration is 1.6CMC, the polyelectrolyte used is Arg 14 , and the weight percent concentration of the assembly solution is 2%, the others are the same as
Ⅳ 配制检测液:同实施方式2; Ⅳ Preparation of detection solution: same as embodiment 2;
Ⅴ 测定催化水解时间:同实施方式2; Ⅴ Determination of catalytic hydrolysis time: same as embodiment 2;
Ⅵ 测定胰蛋白酶活性:同实施方式1;
Ⅵ Determination of trypsin activity: same as
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验: Specificity experiment:
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式5 Embodiment 5
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
除所用荧光探针为BODIPY FL,浓度为10-5 mol L-1,其他同实施方式2; Except that the fluorescent probe used is BODIPY FL, and the concentration is 10 -5 mol L -1 , the others are the same as Embodiment 2;
Ⅱ测定表面活性剂的临界胶束浓度CMC: ⅡDetermination of critical micelle concentration CMC of surfactant:
除所用表面活性剂为十四烷基磺酸钠,荧光探针的终浓度为10-8 mol L-1,其他同实施方式2; Except that the surfactant used is sodium tetradecylsulfonate, and the final concentration of the fluorescent probe is 10 -8 mol L -1 , the others are the same as Embodiment 2;
荧光光谱测定得到表面活性剂的临界胶束浓度。 The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
除表面活性剂浓度为0.6CMC,所用聚电解质为Arg 13 ,组装体溶液的重量百分浓度为0.08%,其他同实施方式1;
Except that the surfactant concentration is 0.6CMC, the polyelectrolyte used is Arg 13 , and the weight percent concentration of the assembly solution is 0.08%, the others are the same as
Ⅳ 配制检测液:同实施方式2; Ⅳ Preparation of detection solution: same as embodiment 2;
Ⅴ 测定催化水解时间:同实施方式2; Ⅴ Determination of catalytic hydrolysis time: same as embodiment 2;
Ⅵ 测定胰蛋白酶活性:同实施方式1;
Ⅵ Determination of trypsin activity: same as
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验: Specificity experiment:
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式6 Embodiment 6
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
除所用荧光探针为BODIPY R6G,其他同实施方式5; Except that the fluorescent probe used is BODIPY R6G, others are the same as embodiment 5;
Ⅱ测定表面活性剂的临界胶束浓度CMC: ⅡDetermination of critical micelle concentration CMC of surfactant:
除所用表面活性剂为十六烷基磺酸钠,其他同实施方式5; Except that surfactant used is sodium cetyl sulfonate, other is the same as embodiment 5;
荧光光谱测定得到表面活性剂的临界胶束浓度。 The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
除表面活性剂浓度为0.5CMC,所用聚电解质为Arg 15 ,组装体溶液的重量百分浓度为0.07%,其他同实施方式1;
Except that the surfactant concentration is 0.5CMC, the polyelectrolyte used is Arg 15 , and the weight percent concentration of the assembly solution is 0.07%, the others are the same as
Ⅳ 配制检测液:同实施方式2; Ⅳ Preparation of detection solution: same as embodiment 2;
Ⅴ 测定催化水解时间:同实施方式2; Ⅴ Determination of catalytic hydrolysis time: same as embodiment 2;
Ⅵ 测定胰蛋白酶活性:同实施方式1;
Ⅵ Determination of trypsin activity: same as
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验: Specificity experiment:
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式7 Embodiment 7
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
除所用荧光探针为BODIPY TMR,其他同实施方式5; Except that the fluorescent probe used is BODIPY TMR, others are the same as embodiment 5;
Ⅱ测定表面活性剂的临界胶束浓度CMC: ⅡDetermination of critical micelle concentration CMC of surfactant:
除荧光探针的终浓度为10-7 mol L-1,其他同实施方式2 Except that the final concentration of the fluorescent probe is 10 -7 mol L -1 , the others are the same as Embodiment 2
荧光光谱测定得到表面活性剂的临界胶束浓度。 The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
除表面活性剂浓度为0.9CMC,所用聚电解质为Arg 11 ,组装体溶液的重量百分浓度为0.12 %,其他同实施方式1;
Except that the surfactant concentration is 0.9CMC, the polyelectrolyte used is Arg 11 , and the weight percent concentration of the assembly solution is 0.12%, the others are the same as in
Ⅳ 配制检测液:同实施方式2; Ⅳ Preparation of detection solution: same as embodiment 2;
Ⅴ 测定催化水解时间:同实施方式2; Ⅴ Determination of catalytic hydrolysis time: same as embodiment 2;
Ⅵ 测定胰蛋白酶活性:同实施方式1;
Ⅵ Determination of trypsin activity: same as
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验: Specificity experiment:
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式8 Embodiment 8
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
除所用荧光探针为BODIPY 581/591,其他同实施方式5; Except that the fluorescent probe used is BODIPY 581/591, the others are the same as Embodiment 5;
Ⅱ测定表面活性剂的临界胶束浓度CMC: ⅡDetermination of critical micelle concentration CMC of surfactant:
除荧光探针的终浓度为10-7 mol L-1,其他同实施方式3; Except that the final concentration of the fluorescent probe is 10 -7 mol L -1 , the others are the same as Embodiment 3;
荧光光谱测定得到表面活性剂的临界胶束浓度。 The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
除表面活性剂浓度为CMC,所用聚电解质为Arg 16 ,其他同实施方式1,组装体溶液的重量百分浓度为0.15%,;
Except that the surfactant concentration is CMC, the polyelectrolyte used is Arg 16 , the others are the same as in
Ⅳ 配制检测液:同实施方式2; Ⅳ Preparation of detection solution: same as embodiment 2;
Ⅴ 测定催化水解时间:同实施方式2; Ⅴ Determination of catalytic hydrolysis time: same as embodiment 2;
Ⅵ 测定胰蛋白酶活性:同实施方式1;
Ⅵ Determination of trypsin activity: same as
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验: Specificity experiment:
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式9 Embodiment 9
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
除所用荧光探针为BODIPY TR,其他同实施方式5; Except that the fluorescent probe used is BODIPY TR, others are the same as embodiment 5;
Ⅱ测定表面活性剂的临界胶束浓度CMC: ⅡDetermination of critical micelle concentration CMC of surfactant:
除荧光探针的终浓度为10-7 mol L-1,其他同实施方式4; Except that the final concentration of the fluorescent probe is 10 -7 mol L -1 , the others are the same as Embodiment 4;
荧光光谱测定得到表面活性剂的临界胶束浓度。 The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
除表面活性剂浓度为1.2CMC,所用聚电解质为Arg 14 ,其他同实施方式1,组装体溶液的重量百分浓度为0.15%,;
Except that the surfactant concentration is 1.2CMC, the polyelectrolyte used is Arg 14 , the others are the same as in
Ⅳ 配制检测液:同实施方式2; Ⅳ Preparation of detection solution: same as embodiment 2;
Ⅴ 测定催化水解时间:同实施方式2; Ⅴ Determination of catalytic hydrolysis time: same as embodiment 2;
Ⅵ 测定胰蛋白酶活性:同实施方式1;
Ⅵ Determination of trypsin activity: same as
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验: Specificity experiment:
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
实施方式10 Embodiment 10
Ⅰ 配制荧光探针的有机溶液: Ⅰ Preparation of organic solution of fluorescent probe:
除所用荧光探针为BODIPY 630/650,其他同实施方式5; Except that the fluorescent probe used is BODIPY 630/650, the others are the same as Embodiment 5;
Ⅱ测定表面活性剂的临界胶束浓度CMC:同实施方式5; II Determination of the critical micelle concentration CMC of the surfactant: same as embodiment 5;
荧光光谱测定得到表面活性剂的临界胶束浓度。 The critical micelle concentration of the surfactant was obtained by fluorescence spectrometry.
Ⅲ 配制超分子组装体溶液: Ⅲ Preparation of supramolecular assembly solution:
除表面活性剂浓度为0.4CMC,所用聚电解质为Arg 12 ,组装体溶液的重量百分浓度为0.05%,其他同实施方式1;
Except that the surfactant concentration is 0.4CMC, the polyelectrolyte used is Arg 12 , and the weight percent concentration of the assembly solution is 0.05%, the others are the same as
Ⅳ 配制检测液:同实施方式2; Ⅳ Preparation of detection solution: same as embodiment 2;
Ⅴ 测定催化水解时间:同实施方式2; Ⅴ Determination of catalytic hydrolysis time: same as embodiment 2;
Ⅵ 测定胰蛋白酶活性:同实施方式1;
Ⅵ Determination of trypsin activity: same as
荧光光谱检测结果表明:发射峰位置荧光强度下降比率与胰蛋白酶浓度有很好的线性关系。 The detection results of fluorescence spectrum showed that the decrease ratio of fluorescence intensity at the emission peak position had a good linear relationship with the concentration of trypsin.
特异性实验: Specificity experiment:
荧光光谱检测结果表明:组装体系对胰蛋白酶检测有很好的特异性,其他蛋白不会影响检测。 The results of fluorescence spectroscopy showed that the assembly system had good specificity for the detection of trypsin, and other proteins would not affect the detection.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210116073.8A CN102680442B (en) | 2012-04-19 | 2012-04-19 | A method for label-free fluorescent detection of trypsin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210116073.8A CN102680442B (en) | 2012-04-19 | 2012-04-19 | A method for label-free fluorescent detection of trypsin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102680442A CN102680442A (en) | 2012-09-19 |
CN102680442B true CN102680442B (en) | 2014-02-26 |
Family
ID=46812703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210116073.8A Expired - Fee Related CN102680442B (en) | 2012-04-19 | 2012-04-19 | A method for label-free fluorescent detection of trypsin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102680442B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102944558B (en) * | 2012-11-30 | 2015-07-29 | 深圳先进技术研究院 | A kind of tryptic detection method |
CN104165869B (en) * | 2013-05-17 | 2016-12-28 | 华中师范大学 | A kind of method detecting hydrolase of proteolysis |
CN103411961B (en) * | 2013-07-15 | 2016-01-06 | 南方医科大学 | A kind of fluorescence measuring critical micelle concentration of surfactant sensitive lights sonde method |
CN103472047B (en) * | 2013-09-26 | 2015-11-18 | 贵州大学 | Amino acid whose fluorescence detection method under a kind of different pH value |
CN104946249B (en) * | 2015-07-10 | 2017-05-10 | 太原理工大学 | A fluorescent probe for trypsin detection and its preparation method |
CN106546564B (en) * | 2016-09-27 | 2019-05-21 | 南方医科大学 | Application of the five substituted-tetrahydro pyrimidine compounds in titration measuring critical micelle concentration of surfactant |
CN107238588B (en) * | 2017-05-12 | 2019-10-22 | 太原理工大学 | A supramolecular assembly for label-free fluorescent detection of trypsin and its preparation method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743638B1 (en) * | 1998-01-21 | 2004-06-01 | The Secretary Of State For Defence | Detection system using liposomes and signal modification |
CN101244833A (en) * | 2008-03-14 | 2008-08-20 | 北京化工大学 | A Method for Determination of Interlayer Molecular Orientation of Naphthalene Acetic Acid Intercalated ZnAl Hydrotalcite Film |
CN101644679A (en) * | 2008-08-05 | 2010-02-10 | 国家纳米科学中心 | Kit and method for using same to detect ATP content, enzyme and medicament |
CN201716317U (en) * | 2010-07-02 | 2011-01-19 | 武汉优尔生科技股份有限公司 | Hog trypsin (TRY) ELISA test kit |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3207120B2 (en) * | 1996-07-24 | 2001-09-10 | 株式会社分子バイオホトニクス研究所 | Enzyme activity measurement method |
US7473535B2 (en) * | 2002-08-20 | 2009-01-06 | The Institute For Systems Biology | Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
-
2012
- 2012-04-19 CN CN201210116073.8A patent/CN102680442B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743638B1 (en) * | 1998-01-21 | 2004-06-01 | The Secretary Of State For Defence | Detection system using liposomes and signal modification |
CN101244833A (en) * | 2008-03-14 | 2008-08-20 | 北京化工大学 | A Method for Determination of Interlayer Molecular Orientation of Naphthalene Acetic Acid Intercalated ZnAl Hydrotalcite Film |
CN101644679A (en) * | 2008-08-05 | 2010-02-10 | 国家纳米科学中心 | Kit and method for using same to detect ATP content, enzyme and medicament |
CN201716317U (en) * | 2010-07-02 | 2011-01-19 | 武汉优尔生科技股份有限公司 | Hog trypsin (TRY) ELISA test kit |
Non-Patent Citations (9)
Title |
---|
A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels;Thierry Rabilloud等;《Proteomics》;20011231;全文 * |
JP特开平10-33197A 1998.02.10 |
Thierry Rabilloud等.A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels.《Proteomics》.2001, |
杨光昕等.荧光探针自组装膜对久效磷农药的检测.《华侨大学学报(自然科学版)》.2010,第31卷(第1期), |
杨涛.超分子自组装形成介孔二氧化硅过程的芘荧光探针光谱表征研究.《硕士学位论文》.2009, |
荧光探针自组装膜对久效磷农药的检测;杨光昕等;《华侨大学学报(自然科学版)》;20100131;第31卷(第1期);全文 * |
表面活性剂类多肽A_6KA_6K的自组装及机理研究;马鑫等;《高等学校化学学报》;20110831;第32卷(第8期);全文 * |
超分子自组装形成介孔二氧化硅过程的芘荧光探针光谱表征研究;杨涛;《硕士学位论文》;20090115;全文 * |
马鑫等.表面活性剂类多肽A_6KA_6K的自组装及机理研究.《高等学校化学学报》.2011,第32卷(第8期), |
Also Published As
Publication number | Publication date |
---|---|
CN102680442A (en) | 2012-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102680442B (en) | A method for label-free fluorescent detection of trypsin | |
Hu et al. | Advantages of time-resolved fluorescent nanobeads compared with fluorescent submicrospheres, quantum dots, and colloidal gold as label in lateral flow assays for detection of ractopamine | |
Jiang et al. | Signal-switchable electrochemiluminescence system coupled with target recycling amplification strategy for sensitive mercury ion and mucin 1 assay | |
Jiang et al. | A selective and light-up fluorescent probe for β-galactosidase activity detection and imaging in living cells based on an AIE tetraphenylethylene derivative | |
Jia et al. | Fluorescence detection of alkaline phosphatase activity with β-cyclodextrin-modified quantum dots | |
Tang et al. | A simple fluorescent probe based on a pyrene derivative for rapid detection of protamine and monitoring of trypsin activity | |
Jiang et al. | Fluorescence detection of protamine, heparin and heparinase II based on a novel AIE molecule with four carboxyl | |
CN110563650A (en) | Ratio type two-photon fluorescent probe of sulfatase, synthetic method and application thereof | |
CN108893106B (en) | Fluorescent probe for detecting high-concentration gamma-glutamyl transpeptidase and preparation method thereof | |
Liu et al. | A convenient and label-free fluorescence “turn off–on” nanosensor with high sensitivity and selectivity for acid phosphatase | |
Gu et al. | Peptide-templated gold nanoclusters as a novel label-free biosensor for the detection of protease activity | |
CN110501317B (en) | Fluorescence detection method for alkaline phosphatase activity | |
US12180183B2 (en) | Water-soluble fluorescent probe and nanoparticals with aggregation-induced emission effect for ovarian cancer and preparation method and use thereof | |
Li et al. | Mass spectrometric multiplex detection of microRNA and protein biomarkers for liver cancer | |
Gao et al. | CuInS 2 quantum dots as a near-infrared fluorescent probe for detecting thrombin in human serum | |
CN103728287A (en) | Fluorescence analysis method for determining glucose by employing nanometer copper oxide as simulated peroxide | |
Fan et al. | A ratiometric fluorescent probe for alkaline phosphatase via regulation of excited‐state intramolecular proton transfer | |
Wang et al. | Fluorescein-inspired near-infrared chemodosimeter for luminescence bioimaging | |
Xu et al. | A peptide-based four-color fluorescent polydopamine nanoprobe for multiplexed sensing and imaging of proteases in living cells | |
Zhang et al. | A new copper mediated on-off assay for alkaline phosphatase detection based on MoOx quantum dots | |
CN104946249B (en) | A fluorescent probe for trypsin detection and its preparation method | |
CN111766290B (en) | Preparation method of biosensor based on three-dimensional titanium carbide-molybdenum disulfide compound | |
Wu et al. | Resolving variable cell viability-induced false negative: Accurate and high-contrast fluorescence diagnosis of cancer enabled by dual organelle targeting and multiple microenvironmental parameters responsive versatile carbon dots | |
CN107121549B (en) | A kind of colorimetric methods of quick detection carcinomebryonic antigen | |
Zheng et al. | Universal sulfatase-based chemiluminescence biosensing platform: Validation via AFP detection in clinical blood samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Jia Lan Inventor after: Li Wenfeng Inventor after: Zhu Jingxin Inventor after: Liu Xiaohua Inventor before: Jia Lan Inventor before: Zhu Jingxin Inventor before: Liu Xiaohua |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: JIA LAN ZHU JINGXIN LIU XIAOHUA TO: JIA LAN LI WENFENG ZHU JINGXIN LIU XIAOHUA |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140226 Termination date: 20170419 |